Edema refers to the body's tissues clearance with the accumulation of excess fluid organizational swelling.Edema can be divided into systemic and local.Systemic edema (usually pitting) occurs when fluid is distributed diffusely between tissues in the body.Fluid accumulation in local interstitial space presented local edema.Occur in the body cavity called effusion, such as pleural effusion, peritoneal effusion, pericardial effusion.In general, the term edema does not include edema of the internal organs, such as cerebral edema, pulmonary edema, etc.The purpose of the edema clinical trial is to assess the efficacy of the drug delivery system, such as baseline vision and mean changes in edema.
This report contains market size and forecasts of Edema Clinical Trials in Global, including the following market information:
Global Edema Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Edema Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Systemic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Edema Clinical Trials include Otsuka Holdings, Roche, CMP Pharma, Syneos Health, GlaxoSmithKline, Boehringer Ingelheim, Sam Chun Dang Pharm and Endo International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Edema Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Edema Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Edema Clinical Trials Market Segment Percentages, by Type, 2021 (%)
Systemic
Local
Global Edema Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Edema Clinical Trials Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Research Organization
Other
Global Edema Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Edema Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Edema Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Edema Clinical Trials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Otsuka Holdings
Roche
CMP Pharma
Syneos Health
GlaxoSmithKline
Boehringer Ingelheim
Sam Chun Dang Pharm
Endo International